Pulmonary toxicity due to chemotherapy. How is the risk and benefit from ZD1839 treatment against non-small cell lung cancer?

Isamu Okamoto, Moritaka Suga

Research output: Contribution to journal › Editorial › peer-review

3 Citations (Scopus)

Fingerprint

Dive into the research topics of 'Pulmonary toxicity due to chemotherapy. How is the risk and benefit from ZD1839 treatment against non-small cell lung cancer?'. Together they form a unique fingerprint.